Viatris (VTRS) Enterprise Value (2018 - 2026)
Viatris (VTRS) recorded quarterly Enterprise Value of -$1.8 billion in Q1 2026, down 36.43% quarter-over-quarter from -$1.3 billion in Q4 2025, and down 138.97% on a YoY basis from $4.6 billion in Q1 2025.
Viatris (VTRS) Enterprise Value (2018 - 2026) Analysis & Trends
Viatris' Enterprise Value history runs 9 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.
- In Q1 2026, Enterprise Value fell 138.97% year-over-year to -$1.8 billion; the TTM figure through Mar 2026 stood at -$1.8 billion (down 138.97% YoY), while the FY2025 annual figure was -$1.3 billion, down 79.65% from the prior year.
- Enterprise Value was -$1.8 billion for Q1 2026 at Viatris, down from -$1.3 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$506.6 million in Q1 2023 to a low of -$1.9 billion in Q3 2024.
- Historically, Enterprise Value has averaged -$984.3 million across 5 years, with a median of -$917.2 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value soared 48.09% in 2025, then slumped 138.97% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$1.3 billion in 2022, then increased by 21.43% to -$991.9 million in 2023, then gained by 25.79% to -$736.1 million in 2024, then sank by 79.65% to -$1.3 billion in 2025, then slumped by 36.43% to -$1.8 billion in 2026.
- The last three Enterprise Value figures came in at -$1.8 billion (Q1 2026), -$1.3 billion (Q4 2025), and -$975.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Viatris | - | - | 1.16 Bn | -1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.80 Bn |
| Dec 31, 2025 | -1.32 Bn |
| Sep 30, 2025 | -975.30 Mn |
| Jun 30, 2025 | -566.40 Mn |
| Mar 31, 2025 | -755.00 Mn |
| Dec 31, 2024 | -736.10 Mn |
| Sep 30, 2024 | -1.88 Bn |
| Jun 30, 2024 | -917.20 Mn |
| Mar 31, 2024 | -1.01 Bn |
| Dec 31, 2023 | -991.90 Mn |
| Sep 30, 2023 | -1.31 Bn |
| Jun 30, 2023 | -629.20 Mn |
| Mar 31, 2023 | -506.60 Mn |
| Dec 31, 2022 | -1.26 Bn |
| Sep 30, 2022 | -646.70 Mn |
| Jun 30, 2022 | -664.70 Mn |
| Mar 31, 2022 | -752.40 Mn |
| Dec 31, 2021 | -706.20 Mn |
| Sep 30, 2021 | -756.60 Mn |
| Jun 30, 2021 | -673.90 Mn |